HU0203102D0 - - Google Patents
Info
- Publication number
- HU0203102D0 HU0203102D0 HU0203102A HUP0203102A HU0203102D0 HU 0203102 D0 HU0203102 D0 HU 0203102D0 HU 0203102 A HU0203102 A HU 0203102A HU P0203102 A HUP0203102 A HU P0203102A HU 0203102 D0 HU0203102 D0 HU 0203102D0
- Authority
- HU
- Hungary
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- AIDS & HIV (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/101,014 US6899890B2 (en) | 2002-03-20 | 2002-03-20 | Bioadhesive drug delivery system |
Publications (3)
Publication Number | Publication Date |
---|---|
HU0203102D0 true HU0203102D0 (hu) | 2002-11-28 |
HUP0203102A2 HUP0203102A2 (hu) | 2004-05-28 |
HUP0203102A3 HUP0203102A3 (en) | 2004-06-28 |
Family
ID=22282669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0203102A HUP0203102A3 (en) | 2002-03-20 | 2002-09-18 | Bioadhesive drug delivery system |
Country Status (17)
Country | Link |
---|---|
US (1) | US6899890B2 (hu) |
EP (1) | EP1494630A4 (hu) |
JP (1) | JP4462818B2 (hu) |
KR (2) | KR20030076159A (hu) |
CN (3) | CN1444926A (hu) |
AR (1) | AR039037A1 (hu) |
AU (2) | AU2002300175B2 (hu) |
BR (1) | BR0202767A (hu) |
CA (1) | CA2392473C (hu) |
FR (1) | FR2837389A1 (hu) |
HU (1) | HUP0203102A3 (hu) |
IT (1) | ITMI20021660A1 (hu) |
MX (1) | MXPA02006943A (hu) |
PT (1) | PT102854B (hu) |
RU (1) | RU2320322C2 (hu) |
WO (1) | WO2003079981A2 (hu) |
ZA (1) | ZA200407535B (hu) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060189552A1 (en) * | 2000-12-12 | 2006-08-24 | Mohan Vishnupad | Dispenser for dispensing three or more actives |
US7060732B2 (en) * | 2000-12-12 | 2006-06-13 | Imaginative Research Associates, Inc. | Antibiotic/benzoyl peroxide dispenser |
US6899890B2 (en) * | 2002-03-20 | 2005-05-31 | Kv Pharmaceutical Company | Bioadhesive drug delivery system |
US20060083759A1 (en) * | 2002-07-17 | 2006-04-20 | Aleksander Resman | Stabilization of the profile of release of active substances from a formulation |
WO2004105662A1 (en) * | 2003-05-23 | 2004-12-09 | Program For Appropriate Technology In Health | Microbicidal compositions and methods of use |
ITTO20030404A1 (it) * | 2003-05-30 | 2004-11-30 | Rottapharm S R L | Composizione per il ripristino dell'ecosistema vaginale |
GB0315671D0 (en) * | 2003-07-04 | 2003-08-13 | Chelsea And Westminster Nhs Tr | Improvements in or relating to organic compounds |
US20060140990A1 (en) | 2003-09-19 | 2006-06-29 | Drugtech Corporation | Composition for topical treatment of mixed vaginal infections |
CN1852690B (zh) | 2003-09-19 | 2010-04-14 | 制药技术有限公司 | 药物输送系统 |
CN1913912B (zh) * | 2003-12-08 | 2010-06-16 | Cpex药品公司 | 用于胰岛素治疗的药用组合物及方法 |
US8057433B2 (en) | 2004-07-08 | 2011-11-15 | Drugtech Corporation | Delivery system |
UA93354C2 (ru) * | 2004-07-09 | 2011-02-10 | Гилиад Сайенсиз, Инк. | Местный противовирусный препарат |
US20060093675A1 (en) * | 2004-10-29 | 2006-05-04 | Mathew Ebmeier | Intravaginal treatment of vaginal infections with metronidazole compositions |
US7619008B2 (en) * | 2004-11-12 | 2009-11-17 | Kimberly-Clark Worldwide, Inc. | Xylitol for treatment of vaginal infections |
US20060217443A1 (en) * | 2005-03-28 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Method for preventing and/or treating vaginal and vulval infections |
BRPI0612968A2 (pt) | 2005-04-27 | 2010-12-14 | Shenzhen Phlora Biotechnology Ltd | uso do Ácido benzàico e/ou seu sal de sàdio em combinaÇço com sacarÍdeos, composiÇço vaginal e mÉtodo para modular a flora vaginal e a acidez vaginal |
WO2006121429A1 (en) * | 2005-05-06 | 2006-11-16 | Imaginative Research Associates, Inc. | Clindamycin compositions and delivery system therefor |
MX2007013631A (es) * | 2005-05-09 | 2008-01-24 | Drugtech Corp | Composiciones farmaceuticas de liberacion modificada. |
US7786176B2 (en) * | 2005-07-29 | 2010-08-31 | Kimberly-Clark Worldwide, Inc. | Vaginal treatment composition containing xylitol |
EP1933810B1 (en) * | 2005-08-11 | 2012-10-10 | Massachusetts Institute of Technology | Intravesical drug delivery device and method |
CN101351188A (zh) * | 2005-08-12 | 2009-01-21 | 药物技术公司 | 雌激素组合物和应用它们的治疗方法 |
WO2007079389A2 (en) * | 2006-01-05 | 2007-07-12 | Drugtech Corporation | Composition and method of use thereof |
US20070154516A1 (en) * | 2006-01-05 | 2007-07-05 | Drugtech Corporation | Drug delivery system |
AR059359A1 (es) * | 2006-02-09 | 2008-03-26 | Schering Corp | Formulaciones farmaceuticas que contienen pleconaril |
EP1872775A1 (en) * | 2006-06-29 | 2008-01-02 | Polichem S.A. | Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
US20080003262A1 (en) * | 2006-06-30 | 2008-01-03 | Drugtech Corporation | Compositions and therapeutic methods of use |
US20080085877A1 (en) * | 2006-08-10 | 2008-04-10 | Drugtech Corporation | Therapeutic methods of using estrogen compositions |
US20080268022A1 (en) * | 2007-02-23 | 2008-10-30 | Mccabe R Tyler | Mehtods for treating and preventing ailments caused by human papillomavirus |
US20080287408A1 (en) * | 2007-05-14 | 2008-11-20 | Drugtech Corporation | Endometriosis treatment |
EP1994938A1 (en) * | 2007-05-21 | 2008-11-26 | Combinature Biopharm AG | New lipoglycodepsipeptide compositions |
AU2008335077B2 (en) | 2007-12-11 | 2014-05-29 | Massachusetts Institute Of Technology | Implantable drug delivery device ant) methods for treatment of the bladder and other body vestcles or lumens |
US20090238867A1 (en) * | 2007-12-13 | 2009-09-24 | Scott Jenkins | Nanoparticulate Anidulafungin Compositions and Methods for Making the Same |
BRPI0917135A2 (pt) | 2008-08-09 | 2015-11-10 | Massachusetts Inst Technology | dispositivo médico para extensão e retenção em uma vesícula seminal, duto ejaculatório, próstata ou vaso deferente de um paciente, uso de um elastômero reabsorvível, e, dispositivo de bomba osmótica. |
US8758730B2 (en) * | 2009-02-26 | 2014-06-24 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
WO2010151893A1 (en) | 2009-06-26 | 2010-12-29 | Taris Biomedical, Inc. | Implantable drug delivery devices and methods of making the same |
US20110008469A1 (en) * | 2009-07-09 | 2011-01-13 | Florida Gulf Coast University | Antimicrobial composition and methods and apparatus for use thereof |
US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
RU2479305C2 (ru) * | 2010-12-06 | 2013-04-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения инфекционных воспалительных заболеваний в гинекологии и способ ее получения |
US9114111B2 (en) | 2011-01-10 | 2015-08-25 | Allergan, Inc. | Methods for sustained treatment of bladder pain and irritative voiding |
KR20140048086A (ko) | 2011-02-04 | 2014-04-23 | 타리스 바이오메디컬 인코포레이티드 | 저 용해성 약물의 제어 방출을 위한 이식가능한 디바이스 |
US9327037B2 (en) | 2011-02-08 | 2016-05-03 | The Johns Hopkins University | Mucus penetrating gene carriers |
ES2615236T3 (es) | 2011-04-04 | 2017-06-06 | Environ Skin Care (Pty) Ltd | Tratamiento de infecciones víricas |
AR086249A1 (es) | 2011-05-02 | 2013-11-27 | Aptalis Pharmatech Inc | Composiciones de tabletas de disolucion rapida de administracion vaginal |
WO2013041935A1 (en) * | 2011-09-19 | 2013-03-28 | Omniactive Health Technologies Limited | An efficient process for the preparation of lycopene containing oleoresin and lycopene crystals for human consumption |
US9180094B2 (en) | 2011-10-12 | 2015-11-10 | The Texas A&M University System | High porosity materials, scaffolds, and method of making |
EP2804632B1 (en) * | 2012-01-19 | 2019-09-18 | The Johns Hopkins University | Nanoparticle formulations with enhanced mucosal penetration |
EP2874824A1 (en) | 2012-07-23 | 2015-05-27 | Crayola LLC | Dissolvable films and methods of using the same |
RU2538703C2 (ru) * | 2013-03-12 | 2015-01-10 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения вагинального кандидоза и способ ее получения |
MX2015012367A (es) | 2013-03-15 | 2016-05-31 | Taris Biomedical Llc | Dispositivos de suministro de farmacos con un componente permeable al farmaco y metodos. |
JP6341200B2 (ja) * | 2013-05-30 | 2018-06-13 | 大正製薬株式会社 | 坐剤 |
CN105530987B (zh) | 2013-08-19 | 2021-07-06 | 塔里斯生物医药公司 | 多单元药物递送装置和方法 |
WO2015070074A2 (en) | 2013-11-08 | 2015-05-14 | The Texas A &M University System | Porous microparticles with high loading efficiencies |
US20150238549A1 (en) * | 2014-02-27 | 2015-08-27 | Mak Wood, Inc. | Probiotic dosage units |
WO2015134500A1 (en) | 2014-03-03 | 2015-09-11 | Cook Medical Technologies Llc | Mechanical dilator |
WO2015175545A1 (en) | 2014-05-12 | 2015-11-19 | The Johns Hopkins University | Highly stable biodegradable gene vector platforms for overcoming biological barriers |
KR102658706B1 (ko) | 2015-04-23 | 2024-04-17 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 성분을 구비한 약물 전달 장치 및 방법 |
RU2017146425A (ru) | 2015-05-29 | 2019-07-02 | Ив Фарма Лтд. | Pн-зависимые вагинальные композиции и способы лечения вагинальных нарушений |
US11166968B2 (en) | 2015-09-29 | 2021-11-09 | Kimberly-Clark Worldwide, Inc. | Synergistic composition for maintenance of healthy balance of microflora |
KR101880179B1 (ko) * | 2016-11-03 | 2018-07-20 | 한국생명공학연구원 | 미카펀진(micafungin) 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 항바이러스용 약학적 조성물 |
AU2017368922A1 (en) * | 2016-11-30 | 2019-05-30 | Probioswiss Ag | Urogenital medical device formulation based on suitable biochemical compositions for the stabilization of the acidity and the redox state of the vaginal fluid |
US12029748B2 (en) | 2017-02-28 | 2024-07-09 | Kimberly-Clark Worldwide, Inc. | Synergistic composition for maintenance of healthy balance of microflora |
BR112021012118A2 (pt) * | 2018-12-19 | 2021-09-08 | Healthy Cow Corporation | Composição probiótica em forma de gel, produto probiótico pronto para uso, kit, sistema, e, métodos para introduzir uma ou mais cepas de bactérias à vagina de um animal não humano, para tratar uma infecção uterina ou diminuir o risco de contrair uma infecção uterina em um animal não humano e para promover o estabelecimento ou manutenção de um microbioma vaginal saudável em um animal não humano |
US11529346B2 (en) * | 2020-06-18 | 2022-12-20 | National Medical Supply, LLC | Vaginal gel |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3988508A (en) | 1973-03-08 | 1976-10-26 | Petrolite Corporation | High internal phase ratio emulsion polymers |
DE3321043A1 (de) * | 1983-06-10 | 1984-12-13 | Bayer Ag, 5090 Leverkusen | Antimykotische mittel fuer einmalige gynaekologische behandlung |
US4551148A (en) | 1982-09-07 | 1985-11-05 | Kv Pharmaceutical Company | Vaginal delivery systems and their methods of preparation and use |
US5266329A (en) | 1985-10-31 | 1993-11-30 | Kv Pharmaceutical Company | Vaginal delivery system |
US5536743A (en) * | 1988-01-15 | 1996-07-16 | Curatek Pharmaceuticals Limited Partnership | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
US4895452A (en) | 1988-03-03 | 1990-01-23 | Micro-Pak, Inc. | Method and apparatus for producing lipid vesicles |
US5055303A (en) | 1989-01-31 | 1991-10-08 | Kv Pharmaceutical Company | Solid controlled release bioadherent emulsions |
CA1337279C (en) | 1989-06-06 | 1995-10-10 | Robert J. Borgman | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
US5298246A (en) | 1991-01-09 | 1994-03-29 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Stable pharmaceutical composition and method for its production |
DE69220317T2 (de) | 1991-10-01 | 1997-10-16 | Takeda Chemical Industries Ltd | Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe |
US5189070A (en) | 1992-05-29 | 1993-02-23 | Shell Oil Company | Process for preparing low density porous crosslinked polymeric materials |
US6191105B1 (en) | 1993-05-10 | 2001-02-20 | Protein Delivery, Inc. | Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin |
US5576016A (en) | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
US5744155A (en) | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
US5470885A (en) | 1993-09-29 | 1995-11-28 | The Research Foundation Of The State University Of New York | Fluorocarbons as anti-inflammatory agents |
TW438601B (en) | 1994-05-18 | 2001-06-07 | Janssen Pharmaceutica Nv | New mucoadhesive emulsion compositions and a process for the preparation thereof |
US5980936A (en) | 1997-08-07 | 1999-11-09 | Alliance Pharmaceutical Corp. | Multiple emulsions comprising a hydrophobic continuous phase |
AU740758B2 (en) | 1997-10-28 | 2001-11-15 | Vivus, Inc. | Treatment of female sexual dysfunction |
US5877216A (en) | 1997-10-28 | 1999-03-02 | Vivus, Incorporated | Treatment of female sexual dysfunction |
US6899890B2 (en) * | 2002-03-20 | 2005-05-31 | Kv Pharmaceutical Company | Bioadhesive drug delivery system |
-
2002
- 2002-03-20 US US10/101,014 patent/US6899890B2/en not_active Expired - Lifetime
- 2002-06-28 CA CA002392473A patent/CA2392473C/en not_active Expired - Lifetime
- 2002-07-10 KR KR1020020039940A patent/KR20030076159A/ko not_active Application Discontinuation
- 2002-07-15 AU AU2002300175A patent/AU2002300175B2/en not_active Ceased
- 2002-07-15 MX MXPA02006943A patent/MXPA02006943A/es active IP Right Grant
- 2002-07-18 BR BR0202767-4A patent/BR0202767A/pt not_active IP Right Cessation
- 2002-07-26 IT IT2002MI001660A patent/ITMI20021660A1/it unknown
- 2002-07-29 CN CN02127087A patent/CN1444926A/zh active Pending
- 2002-07-29 CN CNA2007101048008A patent/CN101045034A/zh active Pending
- 2002-07-29 CN CN2010105156408A patent/CN102048689A/zh active Pending
- 2002-09-12 JP JP2002266381A patent/JP4462818B2/ja not_active Expired - Fee Related
- 2002-09-18 HU HU0203102A patent/HUP0203102A3/hu unknown
- 2002-10-15 PT PT102854A patent/PT102854B/pt not_active IP Right Cessation
- 2002-11-27 FR FR0214858A patent/FR2837389A1/fr active Pending
-
2003
- 2003-03-19 EP EP03714226A patent/EP1494630A4/en not_active Ceased
- 2003-03-19 WO PCT/US2003/008266 patent/WO2003079981A2/en not_active Application Discontinuation
- 2003-03-19 RU RU2004130870/15A patent/RU2320322C2/ru not_active IP Right Cessation
- 2003-03-19 AU AU2003218233A patent/AU2003218233A1/en not_active Abandoned
- 2003-03-20 AR ARP030100979A patent/AR039037A1/es unknown
-
2004
- 2004-09-17 ZA ZA200407535A patent/ZA200407535B/en unknown
-
2008
- 2008-10-29 KR KR1020080106637A patent/KR20080098576A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2320322C2 (ru) | 2008-03-27 |
BR0202767A (pt) | 2004-05-25 |
FR2837389A1 (fr) | 2003-09-26 |
AU2003218233A8 (en) | 2003-10-08 |
EP1494630A4 (en) | 2007-03-14 |
CA2392473C (en) | 2007-09-18 |
WO2003079981A2 (en) | 2003-10-02 |
EP1494630A2 (en) | 2005-01-12 |
WO2003079981A3 (en) | 2003-11-06 |
AU2003218233A1 (en) | 2003-10-08 |
HUP0203102A3 (en) | 2004-06-28 |
US20030180366A1 (en) | 2003-09-25 |
ZA200407535B (en) | 2006-06-28 |
KR20030076159A (ko) | 2003-09-26 |
RU2004130870A (ru) | 2005-06-10 |
PT102854A (pt) | 2003-09-30 |
MXPA02006943A (es) | 2004-12-13 |
HUP0203102A2 (hu) | 2004-05-28 |
CN102048689A (zh) | 2011-05-11 |
JP4462818B2 (ja) | 2010-05-12 |
JP2003286193A (ja) | 2003-10-07 |
CN101045034A (zh) | 2007-10-03 |
AR039037A1 (es) | 2005-02-02 |
ITMI20021660A1 (it) | 2004-01-26 |
AU2002300175B2 (en) | 2004-04-22 |
KR20080098576A (ko) | 2008-11-11 |
PT102854B (pt) | 2004-02-27 |
US6899890B2 (en) | 2005-05-31 |
CN1444926A (zh) | 2003-10-01 |
AU2002300175A1 (en) | 2003-10-09 |
CA2392473A1 (en) | 2003-09-20 |